1Lacour S, Hammann A, Wotawa A, et al. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res, 2001, 61(4): 1645～1651
2Kaminska J, Kowalska MM, Nowacki MP, et al. CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients. Pathol Oncol Res, 2000, 6(1): 38～41
3Kuniyasu H, Oue N, Shigeishi H, et al. Early events in TNF signaling: a story of associations and dissociations. J Leukoc Biol, 1997, 61(5): 559～566
4Leist M, Gantner F, Jilg S, et al. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol ,1995, 154(3): 1307～1316
5Ramires M, David L, Leitao D, et al. Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas. J Pathol, 1997, 182(1): 62～67
6Sakuma K, Fujimori T, Hirabayashi K, et al. Cyclooxygenase (COX)-2 irmunoreactivity and relationship to p53 and Ki67 expression in colorectal cancer. J Gastroenterol, 1999, 34(2): 189～194
7Tomita A, Fuchino Y, Otsuka K, et al. Clinical effects of exogenous/endogenous TNF therapy on metastatic lesions of 34 colorectal cancer patients. Anticancer Res, 1998, 18 (5D):3937～3939
8Yamasaki K, Hasegawa S, Futami K, et al. Endogenous TNF induction therapy using rTNF-SAM2 in patients with pulmonary metastases from colorectal cancer. Anticancer Res,1998 ,18(5D):3931～3936
9Takagi K, Tomita K, Fukushima Y, et al. Endogenous TNF inducibility and prognosis of colorectal cancer. Anticancer Res, 1998, 18(6A): 4141～4146
